8.29

0.00% 0.00

After Hours: 8.29

Pulmonx Corp (LUNG)

Overview News Price History Option Chain Financials Discussions Forecast

Pulmonx Corp stock is traded at $8.29, with a volume of 223.36K. It is up +0.00% in the last 24 hours and up +13.25% over the past month. Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Previous Close:

$8.29

Open:

$8.28

24h Volume:

223.36K

Relative Volume:

0.73

Market Cap:

$322.81M

Revenue:

$68.68M

Net Income/Loss:

$-60.84M

P/E Ratio:

-5.1491

EPS:

-1.61

Net Cash Flow:

$-38.42M

1W Performance:

+1.22%

1M Performance:

+13.25%

6M Performance:

-10.57%

1Y Performance:

-19.75%

1-Day Range:

$8.07

$8.47

1-Week Range:

$8.05

$8.59

52-Week Range:

$5.46

$14.84

Pulmonx Corp Stock (LUNG) Company Profile

Name

Pulmonx Corp

Sector

Healthcare (1190)

Industry

Medical Devices (154)

Phone

650-364-0400

Address

700 CHESAPEAKE DRIVE, REDWOOD CITY

Employee

279

Twitter

Next Earnings Date

2024-10-28

Latest SEC Filings

LUNG's Discussions on Twitter

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-05-23	Initiated	Craig Hallum	Buy
Feb-27-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-03-23	Downgrade	BofA Securities	Neutral → Underperform
Dec-12-22	Upgrade	Citigroup	Neutral → Buy
Jul-11-22	Downgrade	Citigroup	Buy → Neutral
Mar-02-22	Resumed	BofA Securities	Neutral
Dec-08-21	Upgrade	Piper Sandler	Neutral → Overweight
Apr-01-21	Initiated	Citigroup	Buy
Mar-25-21	Initiated	Piper Sandler	Neutral
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Oct-26-20	Initiated	BofA Securities	Buy
Oct-26-20	Initiated	Canaccord Genuity	Buy
Oct-26-20	Initiated	Morgan Stanley	Equal-Weight
Oct-26-20	Initiated	Stifel	Buy
Oct-26-20	Initiated	Wells Fargo	Equal Weight

View All

Pulmonx Corp Stock (LUNG) Latest News

Sep 25, 2024

Phunware (NASDAQ:PHUN) Stock Price Up 4.2% - Defense World

Sep 25, 2024

Sep 24, 2024

PulteGroup Inc [PHM] Insider FOLLIARD THOMAS J sells 19,000 Shares – Latest News - Knox Daily

Sep 24, 2024

Urban Outfitters, Inc. (NASDAQ:URBN) Shares Sold by Shapiro Capital Management LLC - Defense World

Sep 24, 2024

Sep 23, 2024

Market Recap: Trupanion Inc (TRUP)’s Positive Momentum, Closing at 42.80 - The Dwinnex

Sep 23, 2024

Sep 22, 2024

Bank of New York Mellon Corp Purchases 17,740 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World

Sep 22, 2024

Sep 21, 2024

PulteGroup, Inc. (NYSE:PHM) Shares Sold by MQS Management LLC - Defense World

Sep 21, 2024

Trupanion (NASDAQ:TRUP) Given New $45.00 Price Target at Northland Securities - Defense World

Sep 21, 2024

Texas Permanent School Fund Corp Has $1.08 Million Stake in Trupanion, Inc. (NASDAQ:TRUP) - Defense World

Sep 21, 2024

Sep 20, 2024

Intech Investment Management LLC Purchases 133,283 Shares of PulteGroup, Inc. (NYSE:PHM) - Defense World

Sep 20, 2024

Waterloo Capital L.P. Sells 223 Shares of PulteGroup, Inc. (NYSE:PHM) - Defense World

Sep 20, 2024

Trupanion (NASDAQ:TRUP) Shares Gap Up on Analyst Upgrade - MarketBeat

Sep 20, 2024

Sep 19, 2024

Pulmonx director French Glendon E. III sells $161,800 in company stock - Investing.com Australia

Sep 19, 2024

Sep 18, 2024

Glendon E. French III Sells 20,000 Shares of Pulmonx Co. (NASDAQ:LUNG) Stock - Defense World

Sep 18, 2024

Pulmonx director French Glendon E. III sells $161,800 in company stock - Investing.com Canada

Sep 18, 2024

Pulmonx director French Glendon E. III sells $161,800 in company stock - Investing.com India

Sep 18, 2024

Pulmonx director French Glendon E. III sells $161,800 in company stock - Investing.com

Sep 18, 2024

Pulmonx director French Glendon E. III sells $161,800 in company stock - Investing.com UK

Sep 18, 2024

Sep 09, 2024

Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Sep 09, 2024

Pulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Sep 09, 2024

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 - Yahoo Finance

Sep 09, 2024

Sep 05, 2024

Pulmonx executive sells over $30,000 in company stock - Investing.com India

Sep 05, 2024

Pulmonx corp general counsel sells over $38k in company stock - Investing.com

Sep 05, 2024

Pulmonx corp general counsel sells over $38k in company stock - Investing.com India

Sep 05, 2024

Pulmonx Co. (NASDAQ:LUNG) Insider Geoffrey Beran Rose Sells 4,586 Shares - MarketBeat

Sep 05, 2024

Sep 02, 2024